A patient with classic biphasic pulmonary blastoma harboring CD74–ROS1 fusion responds to crizotinib

Pulmonary blastoma (PB) is a rare aggressive lung malignancy with a poor prognosis. Surgical resection is the treatment of choice for localized disease, and there are no standard treatment guidelines for metastatic PB. Due to its rareness, its molecular profile has not been elucidated. We present th...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Zhaoting, Chen, Peng, Zang, Fenglin, Liu, Ying, Xu, Xiaoyan, Su, Yudong, Chen, Jinliang, Lin, Li, Zhang, Lu, Zhang, Tengfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749379/
https://www.ncbi.nlm.nih.gov/pubmed/29343973
http://dx.doi.org/10.2147/OTT.S150001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749379/
https://www.ncbi.nlm.nih.gov/pubmed/29343973
http://dx.doi.org/10.2147/OTT.S150001

Ejemplares similares